Cannabidiol Effective and Safe at 3 Months for Epilepsy

“New open-label data from the expanded-access treatment program involving the cannabidiol Epidiolex(GW Pharma) show the median reduction in frequency of convulsive seizures after 3 months of treatment was 45% in all patients but higher in those with Dravet syndrome, among the most severe types of epilepsy.

The data are “very positive and promising,” said lead author Orrin Devinsky, MD, professor, neurology, neurosurgery and psychiatry, and director, New York University Comprehensive Epilepsy Center.” http://www.medscape.com/viewarticle/855768

“More Positive Results With Cannabidiol in Epilepsy”  http://www.medscape.com/viewarticle/853781

http://www.thctotalhealthcare.com/category/epilepsy-2/

Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.

“There is a great need for safe and effective therapies for treatment of infantile spasms (IS) and Lennox-Gastaut syndrome (LGS). Based on anecdotal reports and limited experience in an open-label trial, cannabidiol (CBD) has received tremendous attention as a potential treatment for pediatric epilepsy, especially Dravet syndrome.

We sought to document the experiences of children with IS and/or LGS who have been treated with CBD-enriched cannabis preparations.

Perceived efficacy and tolerability were similar across etiologic subgroups.

Eighty-five percent of all parents reported a reduction in seizure frequency, and 14% reported complete seizure freedom.

Reported side effects were far less common during CBD exposure, with the exception of increased appetite (30%).

A high proportion of respondents reported improvement in sleep (53%), alertness (71%), and mood (63%) during CBD therapy… this study suggests a potential role for CBD in the treatment of refractory childhood epilepsy including IS and LGS…”

http://www.ncbi.nlm.nih.gov/pubmed/25935511

“Safety and side effects of cannabidiol, a Cannabis sativa constituent.”  http://www.ncbi.nlm.nih.gov/pubmed/22129319

“Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa…” http://www.ncbi.nlm.nih.gov/pubmed/19690824

http://www.thctotalhealthcare.com/category/epilepsy-2/

Medicinal Marijuana May Help Cure Children With Severe Epilepsy

A marijuana plant

“Recent research found that a liquid form of therapeutic marijuana can provide cure to children with treatment-resistant epilepsy.

The said study will be presented at the American Academy of Neurology’s 67th Annual Meeting in Washington, DC in late April.”

http://au.ibtimes.com/medicinal-marijuana-may-help-cure-children-severe-epilepsy-1440398

http://www.thctotalhealthcare.com/category/epilepsy-2/

Antiepileptic potential of cannabidiol analogs.

“In audiogenic seizure (AGS) susceptible rats, the acute (intraperitoneal and intravenous) dose-response effects of (–)-cannabidiol (CBD) for preventing AGS and for causing rototod neurotoxicity (ROT) were determined.

Also, the anti-AGS and ROT effects of 10 CBD analogs, given in intravenous doses equivalent to the AGS-ED50 (15 mg/kg) and ROT-ID50 (31 mg/kg) of CBD, were ascertained.

Compared to CBD, (–)-CBD diacetate and (–)-4-(2′-olivetyl)-alpha-pinene were equally effective whereas (–)-CBD monomethyl ether, (–)-CBD dimethyl ether, (–)-3′-acetyl-CBD monoacetate, (+)-4-(2′-olivetyl)-alpha-pinene, (–)-and (+)-4-(6′-olivetyl)-alpha-pinene, (+/-)-AF-11, and olivetol were less effective anticonvulsants. Except for (–)- and (+)-4-(2′-olivetyl)-alpha-pinene and olivetol, all analogs showed less ROT than CBD.

Also, CBD and all analogs were not active in tetrahydrocannabinol seizure-susceptible rabbits, the latter a putative model of cannabinoid psychoactivity in humans.

These data suggest anticonvulsant requirements of 2 free phenolic hydroxyl groups, exact positioning of the terpinoid moiety in the resorcinol system and correct stereochemistry.

Moreover, findings of separation of anticonvulsant from neurotoxic and psychoactive activities, notably with CBD diacetate, suggest that additional structural modifications of CBD may yield novel antiepileptic drugs.”

http://www.ncbi.nlm.nih.gov/pubmed/7298873

http://www.thctotalhealthcare.com/category/epilepsy-2/

The case for medical marijuana in epilepsy.

“Charlotte, a little girl with SCN1A-confirmed Dravet syndrome, was recently featured in a special that aired on CNN. Through exhaustive personal research and assistance from a Colorado-based medical marijuana group (Realm of Caring), Charlotte’s mother started adjunctive therapy with a high concentration cannabidiol/Δ9 -tetrahydrocannabinol (CBD:THC) strain of cannabis, now known as Charlotte’s Web. This extract, slowly titrated over weeks and given in conjunction with her existing antiepileptic drug regimen, reduced Charlotte’s seizure frequency from nearly 50 convulsive seizures per day to now 2-3 nocturnal convulsions per month. This effect has persisted for the last 20 months, and Charlotte has been successfully weaned from her other antiepileptic drugs. We briefly review some of the history, preclinical and clinical data, and controversies surrounding the use of medical marijuana for the treatment of epilepsy, and make a case that the desire to isolate and treat with pharmaceutical grade compounds from cannabis (specifically CBD) may be inferior to therapy with whole plant extracts. Much more needs to be learned about the mechanisms of antiepileptic activity of the phytocannabinoids and other constituents of Cannabis sativa.”

http://www.ncbi.nlm.nih.gov/pubmed/24854149

“Marijuana stops child’s severe seizures”  http://www.cnn.com/2013/08/07/health/charlotte-child-medical-marijuana/

http://www.thctotalhealthcare.com/category/dravet-syndome/

Potential Cure for Epilepsy: Cannabis Vastly Reduces Seizures in Boy with Dravet Syndrome

A judge checks on a marijuana sample during a judging session at Uruguay's second

“Scientists are looking at the potential use of cannabis to treat and potentially cure severe forms of epilepsy.

The medical benefits of medical marijuana for neurological conditions like epilepsy are highly debated.

Examining the potential use of the drug, a series of articles in the journal Epilepsia, a journal of the International League Against Epilepsy, looks at its potential use for treating the syndrome.

Edward Maa, from the Comprehensive Epilepsy Program at Denver Health in Denver, Colorado, looks at a case study of a child with Dravet syndrome – a very severe form of epilepsy.

In the case, a mother provided her child with a strain of medical marijuana high in Cannabidiol (CBD) and tetrahydrocannabinol (THC) known as Charlotte’s Web.

When used with the child’s normal drug regime, seizures dropped from 50 convulsions per day to just two or three per month.”

http://www.ibtimes.co.uk/potential-cure-epilepsy-cannabis-vastly-reduces-seizures-boy-dravet-syndrome-1449505

http://www.thctotalhealthcare.com/category/dravet-syndome/

 

Marijuana Accessible to Children as a Cure for Epileptic Seizures

marijuana

“Recently a 5-year-old child was administered a medical marijuana card, the youngest person to ever receive one. Her parents are nothing less than ecstatic, as this drug has worked wonders to reduce the amount and severity of her chronic, life-threatening epileptic seizures. This new found use for the highly controversial drug has been the reason for much debate, as well as hundreds of families deciding to relocate to Colorado, where marijuana is accessible to children to cure epileptic seizures…”

More: http://guardianlv.com/2014/02/marijuana-accessible-to-children-as-a-cure-for-epileptic-siezures/

Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression.

“To date, anticonvulsant effects of the plant cannabinoid, cannabidivarin (CBDV), have been reported in several animal models of seizure. However, these behaviourally observed anticonvulsant effects have not been confirmed at the molecular level…

These results provide the first molecular confirmation of behaviourally observed effects of the non-psychoactive, anticonvulsant cannabinoid, CBDV, upon chemically-induced seizures and serve to underscore its suitability for clinical development.”

http://www.ncbi.nlm.nih.gov/pubmed/24282673

Full-text: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840466/

Cannabis might be a better treatment for epilepsy sufferers -msn

Young marijuana plants (©AP Photo/Ted S. Warren)

“Cannabis is now apparently the cure for everything from cancer,  diarrhea, bipolar disorder and Multiple sclerosis, to an ailing economy and being a smart aleck teenager. The latest chronic illness to get the 4:20 treatment is epilepsy. British scientists from the University of Reading tested a compound in pot called cannabidivarin on rats and mice with six types of epilepsy, and found it “strongly suppressed seizures” without the unpleasant side effects of current anti-epilepsy drugs. With 1 percent of the world’s population suffering from the disease, the head of the research team, Ben Whalley, says there’s a pressing need for better treatments. “It’s a chronic condition with no cure and currently, in around one-third of cases, the currently available treatments do not work, cause serious side effects and increase fatalities,” he said.”

http://now.msn.com/epilepsy-treatment-found-in-cannabis-may-prove-better-than-current-methods

10-year-old is seizure-free after one year of cannabis oil

Zaki Jackson, seen here with his mom Heather, used to suffer through 200 seizures per hour. - COURTESY HEATHER JACKSON

“Amid the sounds of children laughing as they bounce and roll down a giant, red inflatable slide, a crowd of more than 150 gathers, making a half-circle around Heather Jackson.

“I want to thank you all so much for coming,” Jackson says. “There are some of you I don’t even know — which is awesome. Again, thank you for coming out and helping us celebrate Zaki’s first seizure-free year.”

The crowd applauds. Zaki, Jackson’s 10-year-old son, emerges from the crowd, smiling. His brow gleams from a light sweat, joyfully earned on the inflatable playground at Jump-N-Jacks, an indoor play facility on North Academy Boulevard. His mother puts one arm on his shoulder and fans him with a Realm of Caring laminated fact sheet.

He is normal. He is fine.

One year earlier, Mrs. Jackson sat with a friend who worked in hospice care, asking for advice concerning the next treatment for Zaki’s Doose syndrome, a form of epilepsy found early in childhood. There is no known cause, and the condition is often unresponsive to medication.

Zaki’s seizures began when he was 4 months old. At what his mother calls his “deepest valley,” he experienced thousands per day. A 2008 electroencephalography reading revealed more than 200 per hour. To combat this, the child underwent 17 different pharmaceutical treatments — all of which failed.

As recently as May 2012, Zaki would have between 60 and 200 seizures while he slept. “They were brief, but very violent,” Jackson says. “It was like someone was putting paddles to his chest. Then he began to have seizures where he would stop breathing.

“So my friend at hospice, she said to me, ‘I can’t tell you to try this, but there is this group of brothers who have helped treat a similar case with cannabis oil. I can’t tell you to try it, but here’s some phone numbers.'”

The brothers — Josh, Jordan, Jesse, Joel, Jon and Jared Stanley, cannabis growers and founders of Realm of Caring — created a strain of cannabis containing minimal THC, the psychoactive ingredient, and very high levels of cannabidiol (CBD), the ingredient considered to provide the most medicinal benefits.

At Zaki’s party, Josh Stanley explains: “We were reading these studies in Israel from the ’70s, ’80s, and ’90s — studies where they saw positive results on lab mice using high-CBD strains. So we decided to give it a try, originally focusing on aiding cancer patients. It was by luck that we discovered it could be so beneficial to those suffering from seizures.”

The “luck” came when Paige Figi contacted the Stanley brothers. She had read about high-CBD oils used to treat epilepsy in California. Her 6-year-old daughter, Charlotte, suffers from Dravet syndrome, and she was willing to try anything. The cannabis oil so helped Charlotte, they renamed the strain in her honor: Charlotte’s Web, of which Zaki takes 300 mg every day.

Realm of Caring’s 501(c)3 status is pending, but the Colorado Springs foundation hopes to become a nonprofit that can make alternate treatment affordable for families in need. Meanwhile, back at the party, Jackson announces that Zaki’s last clinical seizure took place Oct. 3, 2012. Her husband, Frank Jackson, presents the Stanley brothers with a wooden sign, which reads “Zaki’s Garden” at the top and “Thank you for my first seizure-free year” at the bottom.

Zaki moves past his mother’s arm, shuffles through the crowd, and speeds toward an inflatable ship as a few friends follow close behind.”

http://www.csindy.com/coloradosprings/10-year-old-is-seizure-free-after-one-year-of-cannabis-oil/Content?oid=2779991